{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:15:15Z","timestamp":1783448115435,"version":"3.55.0"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010135","name":"Finska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010135","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009094","name":"Turun Yliopistollisen Keskussairaalan Koulutus- ja Tutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009094","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010119","name":"Stiftelsen Dorothea Olivia, Karl Walter och Jarl Walter Perkl\u00e9ns Minne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010119","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Western Finland Collaborative Area Research Committee"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Inflammation is an inherent feature of advanced chronic kidney disease (CKD) and associated with adverse outcomes. Several inflammatory biomarkers have been shown to be associated with mortality in CKD. Cell-free DNA (cfDNA) is a novel biomarker for inflammation which has not been previously examined in patients with CKD stage 4\u20135 not undergoing dialysis. cfDNA was extracted from plasma and quantified with Qubit Flex Fluorometer using dsDNA High Sensitivity kit in 138 patients with CKD stage 4\u20135 not undergoing dialysis at baseline and at a control time point of median 2.7 years of follow-up. A ratio of control and baseline measurement adjusted for an increment of one year of follow-up was calculated. Associations between cfDNA at baseline and all-cause mortality, major adverse cardiovascular and cerebrovascular events (MACCE, defined as a composite outcome of acute myocardial infarction, coronary revascularization, ischemic or hemorrhagic stroke and cardiovascular death), emergency room (ER) visits, hospitalizations or incident malignancies were assessed. Within a median follow-up of 6.2 years, no associations were observed between cfDNA and mortality, MACCEs, ER visits, hospitalizations or incident malignancies. cfDNA control measurement and cfDNA delta ratio was available in 101 patients. Patients who had received a kidney transplant by the control cfDNA measurement had significantly higher cfDNA delta ratio compared to patients not on renal replacement therapy (RRT) and those undergoing dialysis (p\u2009&lt;\u20090.001 for both comparisons). Patients undergoing dialysis at the time of the control cfDNA measurement had higher cfDNA delta ratio (p\u2009=\u20090.003) compared to patients not on RRT. The present study is the first to show that cfDNA is not associated with adverse outcomes in patients with advanced CKD not undergoing dialysis at baseline. Furthermore, our results provide unique data on the evolution of cfDNA levels in predialysis CKD stage 4\u20135 patients transitioning to different modalities of RRT.<\/jats:p>","DOI":"10.1371\/journal.pone.0353258","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:27:55Z","timestamp":1783445275000},"page":"e0353258","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma cell-free DNA measured prior to renal replacement therapy initiation is not associated with incident adverse outcomes, hospitalizations or malignancies in chronic kidney disease stage 4\u20135 patients"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2380-6901","authenticated-orcid":true,"given":"Niilo","family":"Liuhto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenni","family":"Tuominen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noora","family":"Manni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Hakam\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roosa","family":"Lankinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomi","family":"Toukola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonna","family":"Virtanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Mets\u00e4rinne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko J.","family":"J\u00e4rvisalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9453-5687","authenticated-orcid":true,"given":"Tapio","family":"Hellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"issue":"9731","key":"pone.0353258.ref001","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis","volume":"375","author":"Consortium Chronic Kidney Disease Prognosis","year":"2010","journal-title":"Lancet"},{"issue":"11","key":"pone.0353258.ref002","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.ekir.2020.08.028","article-title":"Cardiac biomarkers and risk of mortality in CKD (the CRIC Study)","volume":"5","author":"K Wang","year":"2020","journal-title":"Kidney Int Rep"},{"issue":"4","key":"pone.0353258.ref003","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jacc.2021.11.023","article-title":"Association of longitudinal high-sensitivity troponin t with mortality in patients with chronic kidney disease","volume":"79","author":"NC Chesnaye","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"pone.0353258.ref004","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000531191","article-title":"Interleukin-6-to-albumin ratio as a superior predictor of mortality in end-stage kidney disease patients","volume":"54","author":"X Li","year":"2023","journal-title":"Am J Nephrol"},{"issue":"2","key":"pone.0353258.ref005","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1523-1755.2005.00455.x","article-title":"C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease","volume":"68","author":"V Menon","year":"2005","journal-title":"Kidney Int"},{"issue":"9","key":"pone.0353258.ref006","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1159\/000509582","article-title":"Cardiovascular determinants of mortality in advanced chronic kidney disease","volume":"51","author":"R Lankinen","year":"2020","journal-title":"Am J Nephrol"},{"key":"pone.0353258.ref007","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2017.12","article-title":"Cell-free DNA: The role in pathophysiology and as a biomarker in kidney diseases","volume":"20","author":"P Celec","year":"2018","journal-title":"Expert Rev Mol Med"},{"issue":"13","key":"pone.0353258.ref008","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1177\/0961203320957717","article-title":"Cell-free DNA profiling in patients with lupus nephritis","volume":"29","author":"A Truszewska","year":"2020","journal-title":"Lupus"},{"issue":"9","key":"pone.0353258.ref009","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1373\/clinchem.2006.084509","article-title":"Increased concentrations of antibody-bound circulatory cell-free DNA in rheumatoid arthritis","volume":"53","author":"X-Y Zhong","year":"2007","journal-title":"Clin Chem"},{"issue":"10","key":"pone.0353258.ref010","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1158\/2159-8290.CD-21-1252","article-title":"The origin of highly elevated cell-free dna in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer","volume":"13","author":"AK Mattox","year":"2023","journal-title":"Cancer Discov"},{"issue":"1","key":"pone.0353258.ref011","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13054-016-1578-9","article-title":"The role of total cell-free DNA in predicting outcomes among trauma patients in the intensive care unit: a systematic review","volume":"21","author":"M G\u00f6genur","year":"2017","journal-title":"Crit Care"},{"issue":"1","key":"pone.0353258.ref012","doi-asserted-by":"crossref","first-page":"19624","DOI":"10.1038\/s41598-023-46663-2","article-title":"Cell-free DNA as diagnostic and prognostic biomarkers for adult sepsis: A systematic review and meta-analysis","volume":"13","author":"A Charoensappakit","year":"2023","journal-title":"Sci Rep"},{"key":"pone.0353258.ref013","first-page":"101246","article-title":"Cell-free DNA as a potential biomarker for acute myocardial infarction: A systematic review and meta-analysis","volume":"47","author":"E Tan","year":"2023","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"1","key":"pone.0353258.ref014","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.atherosclerosis.2013.12.022","article-title":"Circulating cell-free DNA is associated with cardiometabolic risk factors: The Health 2000 Survey","volume":"233","author":"J Jylh\u00e4v\u00e4","year":"2014","journal-title":"Atherosclerosis"},{"issue":"1","key":"pone.0353258.ref015","doi-asserted-by":"crossref","first-page":"13809","DOI":"10.1038\/s41598-020-70526-9","article-title":"Circulating cell-free DNA level predicts all-cause mortality independent of other predictors in the Health 2000 survey","volume":"10","author":"L Kananen","year":"2020","journal-title":"Sci Rep"},{"issue":"9","key":"pone.0353258.ref016","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"AS Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"5","key":"pone.0353258.ref017","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1046\/j.1523-1755.1999.00422.x","article-title":"Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure","volume":"55","author":"P Stenvinkel","year":"1999","journal-title":"Kidney Int"},{"issue":"2","key":"pone.0353258.ref018","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1523-1755.1999.00273.x","article-title":"Inflammation enhances cardiovascular risk and mortality in hemodialysis patients","volume":"55","author":"J Zimmermann","year":"1999","journal-title":"Kidney Int"},{"issue":"1","key":"pone.0353258.ref019","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11357-022-00590-8","article-title":"Circulating cell-free DNA in health and disease - the relationship to health behaviours, ageing phenotypes and metabolomics","volume":"45","author":"L Kananen","year":"2023","journal-title":"Geroscience"},{"issue":"5","key":"pone.0353258.ref020","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.exger.2012.02.011","article-title":"Circulating cell-free DNA is associated with mortality and inflammatory markers in nonagenarians: the Vitality 90+ Study","volume":"47","author":"J Jylh\u00e4v\u00e4","year":"2012","journal-title":"Exp Gerontol"},{"issue":"5","key":"pone.0353258.ref021","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/ckj\/sfaa115","article-title":"Cell-free DNA as a marker for the outcome of end-stage renal disease patients on haemodialysis","volume":"14","author":"S Coimbra","year":"2020","journal-title":"Clin Kidney J"},{"issue":"10","key":"pone.0353258.ref022","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1093\/ndt\/gfs255","article-title":"Circulating cell-free DNA in hemodialysis patients predicts mortality","volume":"27","author":"D Tovbin","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"pone.0353258.ref023","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1159\/000510771","article-title":"Elevated circulating cell-free DNA in hemodialysis-treated patients is associated with increased mortality","volume":"51","author":"Y Einbinder","year":"2020","journal-title":"Am J Nephrol"},{"issue":"5","key":"pone.0353258.ref024","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/labmed\/lmac018","article-title":"Erythrocyte sedimentation rate in patients with renal insufficiency and renal replacement therapy","volume":"53","author":"A Buckenmayer","year":"2022","journal-title":"Lab Med"},{"issue":"8","key":"pone.0353258.ref025","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/01.TP.0000157773.96534.29","article-title":"Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients","volume":"79","author":"EM Simmons","year":"2005","journal-title":"Transplantation"},{"issue":"24","key":"pone.0353258.ref026","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.3390\/cells12242774","article-title":"Levels of cell-free DNA in kidney failure patients before and after renal transplantation","volume":"12","author":"C Leotta","year":"2023","journal-title":"Cells"},{"issue":"8","key":"pone.0353258.ref027","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1111\/ajt.17047","article-title":"Inflammation in the early phase after kidney transplantation is associated with increased long-term all-cause mortality","volume":"22","author":"TF Heldal","year":"2022","journal-title":"Am J Transplant"},{"key":"pone.0353258.ref028","doi-asserted-by":"crossref","DOI":"10.12659\/AOT.939750","article-title":"Free-circulating nucleic acids as biomarkers in patients after solid organ transplantation","volume":"28","author":"J Raszeja-Wyszomirska","year":"2023","journal-title":"Ann Transplant"},{"issue":"12","key":"pone.0353258.ref029","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1515\/CCLM.2006.252","article-title":"Increase in and clearance of cell-free plasma DNA in hemodialysis quantified by real-time PCR","volume":"44","author":"V Garc\u00eda Moreira","year":"2006","journal-title":"Clin Chem Lab Med"},{"issue":"6378","key":"pone.0353258.ref030","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.aar3247","article-title":"Detection and localization of surgically resectable cancers with a multi-analyte blood test","volume":"359","author":"JD Cohen","year":"2018","journal-title":"Science"},{"issue":"3","key":"pone.0353258.ref031","first-page":"646","article-title":"Free DNA in the serum of cancer patients and the effect of therapy","volume":"37","author":"SA Leon","year":"1977","journal-title":"Cancer Res"},{"key":"pone.0353258.ref032","doi-asserted-by":"crossref","first-page":"1385041","DOI":"10.3389\/fcell.2024.1385041","article-title":"The impact of preanalytical variables on the analysis of cell-free DNA from blood and urine samples","volume":"12","author":"H Peng","year":"2024","journal-title":"Front Cell Dev Biol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0353258","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:28:01Z","timestamp":1783445281000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0353258"}},"subtitle":[],"editor":[{"given":"Masahiro","family":"Sugimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":32,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0353258","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]}}}